Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
Sales | 132,584 | 99,951 | 105,136 | 94,864 | 100,077 |
Cost of Goods | 24,965 | 20,342 | 17,177 | 15,317 | 13,639 |
Gross Profit | 107,619 | 79,609 | 87,959 | 79,547 | 86,438 |
Operating Expenses | 103,434 | 102,048 | 81,433 | 81,115 | 80,608 |
Operating Income | 5,150 | -22,097 | 6,703 | -1,251 | 6,469 |
Interest Expense | 3,489 | 598 | 310 | 133 | 152 |
Other Income | 826 | 202 | -47 | -70 | 1,241 |
Pre-tax Income | 2,487 | -22,493 | 6,346 | -1,454 | 7,558 |
Income Tax | 4,023 | 4,781 | 2,109 | -2,577 | -34 |
Net Income Continuous | -1,536 | -27,274 | 4,237 | 1,123 | 7,592 |
Net Income | $-1,536 | $-27,274 | $4,237 | $1,123 | $7,592 |
EPS Basic Total Ops | -0.11 | -1.96 | 0.31 | 0.08 | 0.57 |
EPS Basic Continuous Ops | -0.11 | -1.96 | 0.31 | 0.08 | 0.57 |
EPS Diluted Total Ops | -0.11 | -1.96 | 0.30 | 0.08 | 0.55 |
EPS Diluted Continuous Ops | -0.11 | -1.96 | 0.30 | 0.08 | 0.55 |
EPS Diluted Before Non-Recurring Items | 0.16 | -0.95 | 0.37 | 0.13 | 0.72 |
EBITDA(a) | $14,037 | $-12,909 | $14,766 | $6,012 | $14,040 |